NeueHealth, Inc. (NYSE:NEUE – Get Free Report) insider Jeffery Michael Craig sold 2,486 shares of NeueHealth stock in a transaction that occurred on Monday, January 6th. The stock was sold at an average price of $7.33, for a total value of $18,222.38. Following the completion of the sale, the insider now directly owns 7,558 shares in the company, valued at $55,400.14. This represents a 24.75 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
NeueHealth Price Performance
NEUE traded up $0.05 on Wednesday, reaching $7.45. 38,124 shares of the company’s stock were exchanged, compared to its average volume of 70,685. NeueHealth, Inc. has a twelve month low of $3.79 and a twelve month high of $16.59. The stock has a market cap of $61.72 million, a PE ratio of -0.15 and a beta of 0.57. The stock’s fifty day moving average price is $5.47 and its 200-day moving average price is $5.38.
Institutional Inflows and Outflows
A number of institutional investors have recently bought and sold shares of NEUE. Renaissance Technologies LLC acquired a new stake in shares of NeueHealth in the second quarter valued at approximately $312,000. Partners Group Holding AG acquired a new position in NeueHealth during the third quarter worth $463,000. Deer Management Co. LLC purchased a new stake in NeueHealth in the 2nd quarter valued at $5,436,000. Finally, NEA Management Company LLC acquired a new stake in shares of NeueHealth in the 2nd quarter worth $14,834,000. 63.88% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
Check Out Our Latest Report on NeueHealth
About NeueHealth
NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.
Read More
- Five stocks we like better than NeueHealth
- Consumer Staples Stocks, Explained
- Moderna Shares Spike on H5N1 News—What’s Next for Investors?
- Why Invest in High-Yield Dividend Stocks?
- Nebius Group (NBIS): A Small-Cap Backed by NVIDIA
- What Do S&P 500 Stocks Tell Investors About the Market?
- Natural Gas Demand to Surge: Top 3 Stocks and ETFs to Consider
Receive News & Ratings for NeueHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeueHealth and related companies with MarketBeat.com's FREE daily email newsletter.